Dr. Reddy’s Laboratories announced the launch of Zenatane (isotretinoin) capsules, the generic version of Roche Laboratories‘ Accutane. Zenatane is indicated for the treatment of severe recalcitrant nodular acne unresponsive to conventional therapy (eg, systemic antibiotics).
Isotretinoin is a retinoid that inhibits sebaceous gland function and keratinization. It also reduces sebaceous gland size and inhibits sebaceous gland differentiation.
Due to the teratogenicity and fetal harm associated with Zenatane, it will only be available through a special restricted distribution program called iPLEDGE. Both the prescriber and pharmacy must be registered through iPLEDGE, and Zenatane may only be dispensed to patients who are also registered and meet all the iPLEDGE requirements.
Zenatane capsules are available in 10mg, 20mg, and 40mg strengths in 30-count boxes as unit dose blisters.
For more information call (908) 203-4900 or visit www.drreddys.com.